Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
prostate cancer
Biotech
MacroGenics' stock crashes after 5 deaths in ADC trial
Having dialed down the dose in response to early-phase data, MacroGenics' stock cratered after reporting five deaths and other adverse events.
Nick Paul Taylor
May 10, 2024 6:00am
Novartis pays $150M for Arvinas' prostate tumor protein degrader
Apr 11, 2024 8:04am
Prostate cancer ADC breaks FibroGen's clinical losing streak
Apr 3, 2024 10:55am
AstraZeneca melds with Fusion in $2B radiopharma buyout
Mar 19, 2024 5:52am
Janux's shares jump 130% following T-cell engager data drop
Feb 27, 2024 10:35am
Pfizer funnels $15M into 3-year cancer care disparity initiative
Feb 5, 2024 10:00am